Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCRI Tissue Testing Registry

NCT00965861 is registered in ClinicalTrials.gov with SCRI Development Innovations, LLC as lead sponsor.

NCT NCT00965861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCRI Tissue Testing Registry
Lead sponsor
SCRI Development Innovations, LLC
Phase
Observational
Overall status
Terminated
Start date
May 31, 2010
Completion date
February 28, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, melanoma, multiple myeloma, myelodysplastic syndrome